HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Primary biliary cirrhosis-related autoantibodies in a large cohort of italian patients with systemic sclerosis.

AbstractOBJECTIVE:
To analyze the prevalence, associations, and fine specificity of autoantibodies to primary biliary cirrhosis (PBC)-associated antigens (MIT3, Sp100, and gp210) in a cohort of Italian patients with systemic sclerosis (SSc).
METHODS:
Sera samples from 201 patients with SSc were tested for antibodies to MIT3, gp210, and Sp100 by ELISA (the PBC screen). Anti-MIT3-positive sera were studied for IgG or IgA isotypes. All sera were analyzed by indirect immunofluorescence on HEp-2 cells and on rodent kidney/stomach/liver tissue sections in order to detect antinuclear and antimitochondrial antibodies (AMA). SSc was selected by American College of Rheumatology criteria and classified based on LeRoy's criteria.
RESULTS:
Forty-three (21.4%) sera samples were positive for PBC screen antibodies. Anti-MIT3 antibodies were detected in 36 samples, anti-Sp100 in 5, and anti-gp210 in 1 sample. The other 3 PBC screen-positive samples showed no specificity for the single antigens. PBC screen-positive patients more frequently showed a limited cutaneous SSc subtype (p = 0.04), anticentromere antibodies (ACA; p = 0.0013), elevated alkaline phosphatase (ALP) (p < 0.0001), PBC (p = 0.002), and AMA (p = 0.008). Teleangiectasia and calcinosis were less frequent in this group of patients. IgG+IgA anti-MIT3-positive patients had higher prevalence of AMA (p = 0.0035), diagnosis of PBC (p = 0.014), and increased ALP (p = 0.039), all considered biochemical markers of severe liver disease.
CONCLUSION:
PBC screen antibodies were detected in 20% of patients with SSc, strongly associated with ACA. ACA+/PBC screen+ patients had higher risk of developing PBC or elevation of ALP.
AuthorsIlaria Cavazzana, Angela Ceribelli, Mara Taraborelli, Micaela Fredi, Gary Norman, Angela Tincani, Minoru Satoh, Franco Franceschini
JournalThe Journal of rheumatology (J Rheumatol) Vol. 38 Issue 10 Pg. 2180-5 (Oct 2011) ISSN: 0315-162X [Print] Canada
PMID21921093 (Publication Type: Journal Article)
Chemical References
  • Antigens, Nuclear
  • Autoantibodies
  • Autoantigens
  • MIT3 fusion protein
  • NUP210 protein, human
  • Nuclear Pore Complex Proteins
  • Recombinant Fusion Proteins
  • SP100 protein, human
Topics
  • Adult
  • Aged
  • Antigens, Nuclear (immunology)
  • Autoantibodies (immunology)
  • Autoantigens (immunology)
  • Female
  • Humans
  • Italy
  • Liver Cirrhosis, Biliary (diagnosis, immunology)
  • Male
  • Middle Aged
  • Nuclear Pore Complex Proteins (immunology)
  • Predictive Value of Tests
  • Recombinant Fusion Proteins (immunology)
  • Scleroderma, Systemic (immunology)
  • Sensitivity and Specificity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: